Moreover, tumor cells from this stage IV sample show upregulation of genes related to EMT, angiogenesis, and metabolic pathways, including those that have been previously associated with tumor progression such as MMP1, S100A2, TSPAN8, and IGFBP2. The gene discussed is S100A2; the disease is neoplasm.